"The US Food and Drug Administration (FDA) has granted accelerated approval of obeticholic acid (Ocaliva, Intercept Pharmaceuticals, Inc) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic (UDCA) in a"...
Eovist Patient Information including How Should I Take
In this Article
- What is gadoxetate (Eovist)?
- What are the possible side effects of gadoxetate (Eovist)?
- What is the most important information I should know about gadoxetate (Eovist)?
- What should I discuss with my health care provider before receiving gadoxetate (Eovist)?
- How is gadoxetate given (Eovist)?
- What happens if I miss a dose (Eovist)?
- What happens if I overdose (Eovist)?
- What should I avoid after receiving gadoxetate (Eovist)?
- What other drugs will affect gadoxetate (Eovist)?
- Where can I get more information?
What should I discuss with my health care provider before receiving gadoxetate (Eovist)?
Gadoxetate can cause a life-threatening condition in people with advanced kidney disease. The symptoms of this condition include:
- burning, itching, swelling, scaling, and tightening or hardening of your skin;
- muscle weakness;
- joint stiffness in your arms, hands, legs, or feet;
- deep bone pain in your ribs or your hips;
- trouble moving; or
- skin redness or discoloration.
Before receiving this medication, tell your doctor if you have kidney disease or if you are on dialysis. You may not be able to receive an MRI with gadoxetate. Also tell your doctor if you have recently received any contrast agents similar to gadoxetate.
To make sure you can safely receive this medication, tell your doctor if you have any of these other conditions:
- high blood pressure;
- liver disease (or liver transplant);
- a heart rhythm disorder;
- a personal or family history of Long QT Syndrome;
- anemia or other red blood cell disorder;
- asthma, hay fever, or a history of food or drug allergies;
- if you are over 60 years old;
- if you have ever had a reaction to a contrast agent; or
- if you have recently had an injury, surgery, or severe infection.
FDA pregnancy category C. It is not known whether gadoxetate will harm an unborn baby. Before you receive this medication, tell your doctor if you are pregnant.
It is not known whether gadoxetate passes into breast milk or if it could harm a nursing baby. You should not breast-feed for at least 10 hours after receiving gadoxetate. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.
How is gadoxetate given (Eovist)?
Gadoxetate is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting during your MRI.
Your doctor or other healthcare provider may want to watch you for a short time after your test is over. This is to make sure you do not have any unwanted side effects or delayed reactions.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.
Gadoxetate can cause you to have unusual results with certain medical tests for at least 24 hours after your MRI. Tell any doctor who treats you that you have received gadoxetate
Additional Eovist Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.